294 Patient-reported outcomes (PROS) in patients (PTS) receiving niraparib in the prima/engot-ov26/gog-3012 trial | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Ovarian cancer

294 Patient-reported outcomes (PROS) in patients (PTS) receiving niraparib in the prima/engot-ov26/gog-3012 trial

Free

Online download statistics by month:

Online download statistics by month: December 2020 to April 2024

	Abstract	Full	Pdf
Dec 2020	41	0	13
Jan 2021	61	0	9
Feb 2021	22	0	6
Mar 2021	30	0	1
Apr 2021	30	0	12
May 2021	8	0	5
Jun 2021	0	0	5
Jul 2021	0	0	4
Aug 2021	0	0	7
Sep 2021	0	0	3
Oct 2021	22	0	17
Nov 2021	34	0	16
Dec 2021	20	0	2
Jan 2022	24	0	1
Feb 2022	24	0	3
Mar 2022	18	0	6
Apr 2022	19	0	5
May 2022	26	0	4
Jun 2022	18	0	6
Jul 2022	48	0	3
Aug 2022	25	0	5
Sep 2022	40	0	6
Oct 2022	14	0	4
Nov 2022	16	0	3
Dec 2022	15	0	0
Jan 2023	28	0	7
Feb 2023	34	0	5
Mar 2023	22	0	3
Apr 2023	22	0	4
May 2023	12	0	0
Jun 2023	6	0	0
Jul 2023	13	0	6
Aug 2023	15	0	3
Sep 2023	10	0	3
Oct 2023	8	0	1
Nov 2023	12	0	3
Dec 2023	46	0	3
Jan 2024	18	0	2
Feb 2024	10	0	7
Mar 2024	9	0	11
Apr 2024	6	0	5
Total	826	0	209